Neuphoria Therapeutics Inc. Accrued Insurance, Current
Neuphoria Therapeutics Inc. (NEUP) had Accrued Insurance, Current of $28.01 thousand as of 2025-12-31, per its 10-Q filed 2026-02-17.
Financial Statements › Notes › Payables and Accruals › Accrued Liabilities, Current
us-gaap:AccruedInsuranceCurrent · last filed 2026-09-18
- 2025-12-31: Accrued Insurance, Current $28.01K.
- 2025-09-30: Accrued Insurance, Current $112.03K.
- 2025-06-30: Accrued Insurance, Current $278.15K.
- 2025-03-31: Accrued Insurance, Current $0.00.
| Period end | Accrued Insurance, Current |
|---|---|
| 2025-12-31 | $28.01K 10-Q · filed 2026-02-17 |
| 2025-09-30 | $112.03K 10-Q · filed 2025-11-14 |
| 2025-06-30 | $278.15K 10-K · filed 2026-09-18 |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-20 |
| 2024-12-31 | $0.00 10-Q · filed 2025-02-14 |
| 2024-09-30 | $78.65K 10-Q · filed 2024-11-14 |
| 2024-06-30 | $311.17K 10-K · filed 2025-09-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |